Agilent Q3 Revenues Increase 22 Percent, Life Sciences up 21 Percent
August 16, 2011
Agilent Q3 Revenues Increase 22 Percent, Life Sciences up 21 Percent
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Agilent Q3 Revenues Rise 22 Percent as Mass Spec Performs 'Exceptionally Well'
August 19, 2011 / ProteoMonitor - Agilent, University of Western Australia Building Plant Protein Monitoring Database
August 17, 2011 / GenomeWeb Daily News - Hutch, Broad Teams Publish Comprehensive Methods for MS-Based Biomarker Discovery and Verification
July 29, 2011 / ProteoMonitor - NGS-Based Peptide Display Platform Enables Proteome-Wide Screening for Autoantigens
May 27, 2011 / ProteoMonitor - Agilent Posts 32 Percent Jump in Q2 Revenues, Strong LC and Mass Spec Sales
May 13, 2011 / ProteoMonitor